| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01dc12661ed2d8a4ebb867417d1f7f9d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7697c19360a643e9680367da709ab1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_625371897d5869a37aa31b00dc865274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ef4041c8e2266092bc92a37a85e20e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e61cea458f5a1afbf2b789ae7669c134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad734ba1259028ab8c7248b89de0a86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67e4e4b0f0ea8a341ca2166340aa84a |
| publicationDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2007319848-B2 |
| titleOfInvention |
Compounds and methods for inhibiting the interaction of Bcl proteins with binding partners |
| abstract |
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit BcI function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer. |
| priorityDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |